Author:
Shatirishvili M,Burk A S,Franz C M,Pace G,Kastilan T,Breuhahn K,Hinterseer E,Dierich A,Bakiri L,Wagner E F,Ponta H,Hartmann T N,Tanaka M,Orian-Rousseau V
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology
Reference62 articles.
1. Orian-Rousseau V . CD44, a therapeutic target for metastasising tumours. Eur J Cancer 2010; 46: 1271–1277.
2. Wheatley SC, Isacke CM, Crossley PH . Restricted expression of the hyaluronan receptor, CD44, during postimplantation mouse embryogenesis suggests key roles in tissue formation and patterning. Development 1993; 119: 295–306.
3. Bennett KL, Jackson DG, Simon JC, Tanczos E, Peach R, Modrell B et al. CD44 isoforms containing exon v3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol 1995; 128: 687–698.
4. Sherman L, Wainwright D, Ponta H, Herrlich P . A splice variant of CD44 expressed in the apical ectodermal ridge presents fibroblast growth factors to limb mesenchyme and is required for limb outgrowth. Genes Dev 1998; 12: 1058–1071.
5. Volz Y, Koschut D, Matzke-Ogi A, Dietz MS, Karathanasis C, Richert L et al. Direct binding of hepatocyte growth factor and vascular endothelial growth factor to CD44v6. Biosci Rep 2015; 35: pii: e00236.
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献